Peters Malte bought TNGX
January 8, 2026 · Form 4 insider transaction
Peters Malte bought 350,000 shares of Tango Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
350,000
Price
$0.00
Total value
N/A
InsiderPeters Malte
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 8, 2026
Filing dateJanuary 12, 2026
Shares owned after367,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on February 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.